| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/07/2001 | EP1074253A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 02/07/2001 | EP1074248A1 Delivery system for biological material |
| 02/07/2001 | EP1073905A1 Methods of selecting internalizing antibodies |
| 02/07/2001 | EP1073693A1 Coprecipitation of cellulose esters with functional additives and compositions thus obtainable |
| 02/07/2001 | EP1073671A1 Targeted gene delivery to cells by filamentous bacteriophage |
| 02/07/2001 | EP1073474A1 Improvements in or relating to contrast agents |
| 02/07/2001 | EP1073470A1 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 02/07/2001 | EP1073469A1 Stable mitoxantron solutions |
| 02/07/2001 | EP1073468A1 Use of an adhesive composition over a bioactive polymerization initiator or accelerator |
| 02/07/2001 | EP1073467A2 Cosolvent formulations |
| 02/07/2001 | EP1073463A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 02/07/2001 | EP1073462A2 Hepatitis vaccine |
| 02/07/2001 | EP1073460A1 Nucleic acid encoding hyaluronan synthase and methods of use |
| 02/07/2001 | EP1073459A1 Compositions and methods for tolerization in immune complex-mediated disease progression |
| 02/07/2001 | EP1073442A1 Combination viral-based and gene-based therapy of tumors |
| 02/07/2001 | EP1073439A1 Pharmaceutical composition |
| 02/07/2001 | EP1073438A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 02/07/2001 | EP1073424A1 Pellets having a core coated with a lipid lowering agent and a polymer |
| 02/07/2001 | EP1073422A1 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 02/07/2001 | EP1073421A1 Stabilized protein crystals, formulations containing them and methods of making them |
| 02/07/2001 | EP1073418A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 02/07/2001 | EP1073417A1 Pharmaceutical aerosol formulation |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | EP1073413A1 Methods and compositions for stabilizing acetylcholine compositions |
| 02/07/2001 | EP1073401A1 Topical anesthetic formulation |
| 02/07/2001 | EP0696921B1 Veterinary composition containing a proton pump inhibitor |
| 02/07/2001 | CN1283123A Sustained release medicinal compositions |
| 02/07/2001 | CN1283122A Sustained release medicinal compositions |
| 02/07/2001 | CN1283117A Orally administrable solid ribavirin dosafe forms and process for making them |
| 02/07/2001 | CN1283112A Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 02/07/2001 | CN1283111A Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 02/07/2001 | CN1283110A Tablet for instant and prolonged release of one or more active substances |
| 02/07/2001 | CN1283107A Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates |
| 02/07/2001 | CN1283106A Pharmaceutical compositions comprising micelles comprising lipophilic glucoiorticosteroid and only one surfactant |
| 02/07/2001 | CN1283105A Water-soluble eye drop |
| 02/07/2001 | CN1283083A Revitalisation formulation |
| 02/07/2001 | CN1282581A Medicine composition |
| 02/07/2001 | CN1282577A Application of dimethyl sulfoxide in improving sensitivity of antibiotics to bacteria |
| 02/07/2001 | CN1282571A Use of crosslinked cation polymer in skin cosmetics and skin disease preparations |
| 02/07/2001 | CN1061536C Tablet for clearing head for cerebrorascular disease |
| 02/06/2001 | US6184374 Targeted cytotoxic anthracycline analogs |
| 02/06/2001 | US6184358 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor |
| 02/06/2001 | US6184356 Globin protein; for amplifying oxygen carrying capacity of a blood substitute |
| 02/06/2001 | US6184313 Hybrid silane dendrimer-star polymers |
| 02/06/2001 | US6184220 Low viscosity acid enolcarboxamide non-steroidal antiinflammatory drug (nsaid) suspension stabilised by a low concentration of dispersed silica in the presence of a water soluble cellulose ether |
| 02/06/2001 | US6184213 Diluent and disintegrating composition, its method of achievement and its use |
| 02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
| 02/06/2001 | US6184199 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 02/06/2001 | US6184037 Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| 02/06/2001 | US6184030 Biologically-active polymers |
| 02/06/2001 | US6184013 Antibody for reducing concentration of drug in patient |
| 02/06/2001 | US6184009 Process for the preparation of materials with a high content of conjugated long chain polyunsaturated fatty acids |
| 02/06/2001 | US6183783 Bringing the suspension of an active material and a polar polymer insoluble in co2 into contact with liquid co2 so as to desolvate in a controlled way the substantially polar polymer and to provide its coacervation |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183766 Lipophilic skin moisturizing agent; degreasing agent selected from the group consisting of: silicones, wax materials, powders, fluorochemicals and mixtures thereof; optionally a thickener, a humectant, a perfume; and water. |
| 02/06/2001 | US6183762 Method for preparing the emulsions and the use of the emulsions in various domestic and industrial compositions. |
| 02/06/2001 | US6183758 Phytochemicals, nutrients & medication absorption &/or treatment |
| 02/06/2001 | US6183738 Modified arginine deiminase |
| 02/06/2001 | US6183737 Bonding of cartilage pieces using isolated chondrocytes and a biological gel |
| 02/06/2001 | US6183719 High surface area alumina solid |
| 02/06/2001 | CA2315309A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of affinity chromatography |
| 02/06/2001 | CA2315306A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 02/06/2001 | CA2003538C Collagen-polymer conjugates |
| 02/01/2001 | WO2001007914A1 Fenretinide increases antibody cellular toxicity |
| 02/01/2001 | WO2001007604A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | WO2001007507A1 Pullulan film compositions |
| 02/01/2001 | WO2001007486A1 A biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007469A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 02/01/2001 | WO2001007454A1 Enzyme catalyzed therapeutic activation |
| 02/01/2001 | WO2001007442A1 Beta-amyloid peptide inhibitors |
| 02/01/2001 | WO2001007428A1 METHOD FOR PREPARING A η-UNSATURATED β-LACTONE AND USE THEREOF AS AN AROMATIC AND FLAVOURING INGREDIENT |
| 02/01/2001 | WO2001007086A1 Preserved pharmaceutical formulations |
| 02/01/2001 | WO2001007075A2 Multi-dose erythropoietin formulations |
| 02/01/2001 | WO2001007067A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2001007058A2 Parenteral cisplatin emulsion |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007049A2 Ophthalmic composition comprising ketotifen |
| 02/01/2001 | WO2001007018A1 Patches for external use |
| 02/01/2001 | WO2001007017A1 Transdermal therapeutic system for administering a calcium antagonist |
| 02/01/2001 | WO2001007016A1 Process for the production of soft capsules and coating materials and lubricants to be used therefor |
| 02/01/2001 | WO2001007015A2 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 02/01/2001 | WO2001007013A2 Thioamide moiety-containing polymer drug conjugates |
| 02/01/2001 | WO2001007011A1 Method for releasing an agent from a red blood cell |
| 02/01/2001 | WO2001007009A1 Lysine oxidase linkage of agents to tissue |
| 02/01/2001 | WO2001006993A1 Oil-in-water emulsion composition |
| 02/01/2001 | WO2001006991A1 Oil-in-water emulsion with improved stability |
| 02/01/2001 | WO2001006987A2 Transnasal anticonvulsive compositions and modulated process |
| 02/01/2001 | WO2000063248A3 Highly purified gonadotropin compositions and process for preparing them |
| 02/01/2001 | WO2000061175A3 Use of pegylated interferon alpha in melanoma therapy |
| 02/01/2001 | WO2000061116A3 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 02/01/2001 | WO2000056362A3 Polycationic carbohydrates as immunostimulants in vaccines |
| 02/01/2001 | WO2000056357A3 Staphylococcus antigen and vaccine |
| 02/01/2001 | WO2000033818A9 Sustained release tablet containing hydrocolloid and cellulose ether |
| 02/01/2001 | WO1999066951A8 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 02/01/2001 | WO1999065461A9 Cationic amphiphile micellar complexes |
| 02/01/2001 | DE19900764C1 Malatyl-Polysaccharide, deren Herstellung und Verwendung Malatyl polysaccharides, their preparation and use |